rs7221818

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000573619.1(ENSG00000285471):​c.-381+9181G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.663 in 152,092 control chromosomes in the GnomAD database, including 33,883 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 33883 hom., cov: 32)

Consequence

ENSG00000285471
ENST00000573619.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.73

Publications

6 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000573619.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.803 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000573619.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LOC339166
NR_040000.1
n.904+9181G>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000285471
ENST00000573619.1
TSL:2
c.-381+9181G>A
intron
N/AENSP00000461865.1I3NI40
ENSG00000284837
ENST00000563763.5
TSL:1
n.904+9181G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.663
AC:
100762
AN:
151974
Hom.:
33845
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.750
Gnomad AMI
AF:
0.719
Gnomad AMR
AF:
0.532
Gnomad ASJ
AF:
0.728
Gnomad EAS
AF:
0.824
Gnomad SAS
AF:
0.688
Gnomad FIN
AF:
0.644
Gnomad MID
AF:
0.601
Gnomad NFE
AF:
0.625
Gnomad OTH
AF:
0.663
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.663
AC:
100845
AN:
152092
Hom.:
33883
Cov.:
32
AF XY:
0.664
AC XY:
49341
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.750
AC:
31094
AN:
41468
American (AMR)
AF:
0.531
AC:
8116
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.728
AC:
2525
AN:
3470
East Asian (EAS)
AF:
0.823
AC:
4268
AN:
5184
South Asian (SAS)
AF:
0.688
AC:
3312
AN:
4816
European-Finnish (FIN)
AF:
0.644
AC:
6814
AN:
10576
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.625
AC:
42490
AN:
67982
Other (OTH)
AF:
0.659
AC:
1389
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1736
3473
5209
6946
8682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.641
Hom.:
48703
Bravo
AF:
0.658
Asia WGS
AF:
0.728
AC:
2532
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.18
DANN
Benign
0.30
PhyloP100
-1.7

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7221818;
hg19: chr17-5801331;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.